- Home
- VNDA vs PVBC Comparison
VNDA vs PVBC Comparison
Compare VNDA & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- PVBC
- Stock Information
- Founded
- VNDA 2002
- PVBC 1913
- Country
- VNDA United States
- PVBC United States
- Employees
- VNDA N/A
- PVBC N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- VNDA Health Care
- PVBC Finance
- Exchange
- VNDA Nasdaq
- PVBC Nasdaq
- Market Cap
- VNDA 249.4M
- PVBC 222.3M
- IPO Year
- VNDA 2006
- PVBC 2015
- Fundamental
- Price
- VNDA $5.46
- PVBC $12.51
- Analyst Decision
- VNDA Strong Buy
- PVBC Hold
- Analyst Count
- VNDA 2
- PVBC 1
- Target Price
- VNDA $16.50
- PVBC $12.50
- AVG Volume (30 Days)
- VNDA 503.6K
- PVBC 31.8K
- Earning Date
- VNDA 11-05-2025
- PVBC 10-23-2025
- Dividend Yield
- VNDA N/A
- PVBC N/A
- EPS Growth
- VNDA N/A
- PVBC 47.58
- EPS
- VNDA N/A
- PVBC 0.62
- Revenue
- VNDA $203,467,000.00
- PVBC $59,149,000.00
- Revenue This Year
- VNDA $15.45
- PVBC $9.73
- Revenue Next Year
- VNDA $37.82
- PVBC $4.87
- P/E Ratio
- VNDA N/A
- PVBC $20.26
- Revenue Growth
- VNDA 11.78
- PVBC 0.70
- 52 Week Low
- VNDA $3.81
- PVBC $10.11
- 52 Week High
- VNDA $5.59
- PVBC $13.02
- Technical
- Relative Strength Index (RSI)
- VNDA 67.52
- PVBC N/A
- Support Level
- VNDA $5.22
- PVBC N/A
- Resistance Level
- VNDA $5.48
- PVBC N/A
- Average True Range (ATR)
- VNDA 0.21
- PVBC 0.00
- MACD
- VNDA 0.06
- PVBC 0.00
- Stochastic Oscillator
- VNDA 90.31
- PVBC 0.00
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.